Search Results - "SHRAM, Megan J"

Refine Results
  1. 1

    Assessment of the physical dependence potential of difelikefalin: Randomized placebo-controlled study in patients receiving hemodialysis by Spencer, Robert H, Munera, Catherine, Shram, Megan J, Menzaghi, Frédérique

    Published in Clinical and translational science (01-09-2023)
    “…Difelikefalin is a selective kappa opioid receptor agonist approved for treating moderate-to-severe pruritus in adults undergoing hemodialysis (HD)…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Evaluation of the abuse potential of difelikefalin, a selective kappa‐opioid receptor agonist, in recreational polydrug users by Shram, Megan J., Spencer, Robert H., Qian, Jenny, Munera, Catherine L., Lewis, Michael E., Henningfield, Jack E., Webster, Lynn, Menzaghi, Frédérique

    Published in Clinical and translational science (01-02-2022)
    “…Difelikefalin, a selective kappa‐opioid receptor agonist with limited central nervous system penetration, is being developed for the treatment of chronic…”
    Get full text
    Journal Article
  4. 4

    Sex differences in yohimbine-induced increases in the reinforcing efficacy of nicotine in adolescent rats by Li, Sophia, Zou, Sheng, Coen, Kathleen, Funk, Douglas, Shram, Megan J., Lê, A.D.

    Published in Addiction biology (01-03-2014)
    “…Stress is an important factor in the initiation and maintenance of smoking in adolescents. Women are more vulnerable to the development of addiction to smoking…”
    Get full text
    Journal Article
  5. 5

    Adolescent male Wistar rats are more responsive than adult rats to the conditioned rewarding effects of intravenously administered nicotine in the place conditioning procedure by Shram, Megan J., Lê, Anh D.

    Published in Behavioural brain research (20-01-2010)
    “…The initiation of smoking typically begins during adolescence, suggesting that nicotine may have different motivational effects during this developmental stage…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Use of Remifentanil in a Novel Clinical Paradigm to Characterize Onset and Duration of Opioid Blockade by Samidorphan, a Potent μ-Receptor Antagonist by Shram, Megan J, Silverman, Bernard, Ehrich, Elliot, Sellers, Edward M, Turncliff, Ryan

    Published in Journal of clinical psychopharmacology (01-06-2015)
    “…A novel clinical study design was used to evaluate the blockade of a selective short-acting μ-opioid agonist (remifentanil) in 24 opioid-experienced subjects…”
    Get full text
    Journal Article
  8. 8

    Oral, intranasal, and intravenous abuse potential of serdexmethylphenidate, a novel prodrug of d-methylphenidate by Shram, Megan J., Setnik, Beatrice, Webster, Lynn, Guenther, Sven, Mickle, Travis C., Braeckman, Rene, Kanski, Jaroslaw, Martin, Andrea, Kelsh, Debra, Vince, Bradley D., Barrett, Andrew C.

    Published in Current medical research and opinion (03-07-2022)
    “…Serdexmethylphenidate (SDX) chloride (Cl) is a novel prodrug of d-methylphenidate (d-MPH). These studies evaluated the abuse potential of SDX Cl when…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Identification of Optimal Measures of Human Abuse Potential: A Post Hoc Assessment of 19 Studies by Shram, Megan J., Levy-Cooperman, Naama, Ratcliffe, Sian, Mills, Catherine, Bartlett, Cynthia, Chen, Nancy, Setnik, Beatrice, Sellers, Edward M., Schoedel, Kerri A.

    Published in Journal of clinical psychopharmacology (01-11-2020)
    “…Human abuse potential studies include multiple measures to assess the subjective effects of central nervous system-active drugs. In this retrospective…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13

    Nicotine Self-Administration, Extinction Responding and Reinstatement in Adolescent and Adult Male Rats: Evidence Against a Biological Vulnerability to Nicotine Addiction during Adolescence by SHRAM, Megan J, FUNK, Douglas, ZHAOXIA LI, LE, Anh D

    Published in Neuropsychopharmacology (New York, N.Y.) (01-03-2008)
    “…Initiation of smoking behavior typically occurs during adolescence and rarely occurs during adulthood. Despite this epidemiological evidence, relatively little…”
    Get full text
    Journal Article
  14. 14

    Periadolescent and adult rats respond differently in tests measuring the rewarding and aversive effects of nicotine by SHRAM, Megan J, FUNK, Douglas, ZHAOXIA LI, LE, Anh D

    Published in Psychopharmacologia (01-06-2006)
    “…Initiation of tobacco use typically begins during adolescence, and the nature of these first experiences with nicotine may affect the probability of continued…”
    Get full text
    Journal Article
  15. 15

    Abuse Potential of Buprenorphine/Samidorphan Combination Compared to Buprenorphine and Placebo: A Phase 1 Randomized Controlled Trial by Pathak, Sanjeev, Vince, Bradley, Kelsh, Debra, Shram, Megan J., Setnik, Beatrice, Lu, Hong, Nangia, Narinder, Stanford, Arielle D., Ehrich, Elliot

    Published in Journal of clinical pharmacology (01-02-2019)
    “…Buprenorphine/samidorphan combination (BUP/SAM) is an opioid system modulator being investigated as adjunctive treatment for major depressive disorder. BUP/SAM…”
    Get full text
    Journal Article
  16. 16

    Effects of stressors on the reinforcing efficacy of nicotine in adolescent and adult rats by Zou, Sheng, Funk, Douglas, Shram, Megan J., Lê, A. D.

    Published in Psychopharmacology (01-04-2014)
    “…Rationale and objectives Stress increases drug intake. This depends on the stressor, drug, and aspect of drug seeking assessed. The objectives of these…”
    Get full text
    Journal Article
  17. 17

    Evaluation of the Abuse Potential of Extended Release Hydromorphone Versus Immediate Release Hydromorphone by SHRAM, Megan J, SATHYAN, Gayatri, KHANNA, Sarita, TUDOR, Iulia Cristina, NATH, Rajneesh, THIPPHAWONG, John, SELLERS, Edward M

    Published in Journal of clinical psychopharmacology (01-02-2010)
    “…Immediate release (IR) hydromorphone has experienced significant misuse and abuse. An extended release (ER) hydromorphone formulation has been developed to…”
    Get full text
    Journal Article
  18. 18

    Age differences in the spontaneous acquisition of nicotine self-administration in male Wistar and Long–Evans rats by Shram, Megan J., Li, Zhaoxia, Lê, Anh D.

    Published in Psychopharmacologia (01-03-2008)
    “…Rationale Epidemiological evidence suggests that adolescents may exhibit a unique susceptibility to the motivational effects of nicotine compared to adults. In…”
    Get full text
    Journal Article
  19. 19

    Acute nicotine enhances c-fos mRNA expression differentially in reward-related substrates of adolescent and adult rat brain by Shram, Megan J., Funk, Douglas, Li, Zhaoxia, Lê, A.D.

    Published in Neuroscience letters (18-05-2007)
    “…A number of studies have demonstrated that adolescent rodents are more sensitive to the rewarding effects of nicotine compared to adults. To help determine the…”
    Get full text
    Journal Article
  20. 20

    Pharmacokinetic and Pharmacodynamic Correlations From 2 Studies Evaluating Abuse Potential of Hydrocodone Extended‐Release Tablets by Schoedel, Kerri A., Gillespie, Michael, Levy‐Cooperman, Naama, Shram, Megan J., Rabinovich‐Guilatt, Laura

    Published in Clinical pharmacology in drug development (01-01-2019)
    “…Pharmacokinetic (PK)/pharmacodynamic (PD) correlations were explored in 2 human abuse potential studies of orally and intranasally administered hydrocodone…”
    Get full text
    Journal Article